Louis Feinberg

Gründer bei Sporos Bioventures, Inc.

Health Services

Ursprung des Netzwerks ersten Grades von Louis Feinberg

Einheit	Art der Einheit	Industrie
Sporos Bioventures, Inc. Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. 8	Holding Company	Medical/Nursing Services	8

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Louis Feinberg

Unternehmen	Sektor	Verknüpfte Personen	Hauptposition
BRISTOL-MYERS SQUIBB COMPANY	Pharmaceuticals: Major	Rachel Humphrey	Corporate Officer/Principal
ELI LILLY AND COMPANY	Pharmaceuticals: Major	Rachel Humphrey	Corporate Officer/Principal
Oppenheimer & Co., Inc. Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY.	Investment Managers	Peter Feinberg	Corporate Officer/Principal
Schering-Plough Europe SA		Stephen Rubino	Corporate Officer/Principal
RADIUS HEALTH, INC.	Biotechnology	Michael Wyzga	Chief Executive Officer
Harvard University Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.	College/University	Rachel Humphrey	Undergraduate Degree
GPC Biotech, Inc. GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA.	Drugstore Chains	Jeno Gyuris	Corporate Officer/Principal
Sovereign Hill Software, Inc. Sovereign Hill Software, Inc. Packaged SoftwareTechnology Services Part of LeadingSide, Inc., Sovereign Hill Software, Inc. supplies next generation software products. The company is based in Hadley, MA. Sovereign Hill Software was acquired by LeadingSide, Inc. on January 04, 1999 for $1.70 million.	Packaged Software	Michael Wyzga	Director of Finance/CFO
MIRATI THERAPEUTICS	Biotechnology	Rachel Humphrey	Chief Tech/Sci/R&D Officer
Case Western Reserve University Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH.	College/University	Rachel Humphrey	Doctorate Degree
The University of Texas at Austin	College/University	Alex M. Cranberg	Undergraduate Degree
Providence College	College/University	Michael Wyzga	Masters Business Admin
Whittier College	College/University	Peter Feinberg	Undergraduate Degree
Baruch College	College/University	Stephen Rubino	Masters Business Admin
AVEO PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Jeno Gyuris	Chief Tech/Sci/R&D Officer
Aspect Energy LLC (Colorado) Aspect Energy LLC (Colorado) Oil & Gas ProductionEnergy Minerals Aspect Energy LLC operates as an exploration and energy investment company. The firm is engaged in oil and gas exploration and development efforts. The company was founded in 1992 and is headquartered in Denver, CO.	Oil & Gas Production	Alex M. Cranberg	Founder
CytomX Therapeutics Holdings LLC CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA.	Pharmaceuticals: Major	Rachel Humphrey	Corporate Officer/Principal
University of Szeged	College/University	Jeno Gyuris	Doctorate Degree
CELYAD ONCOLOGY SA	Biotechnology	Stephen Rubino	Corporate Officer/Principal
Weill Cornell Medical College	College/University	Stephen Rubino	Doctorate Degree
Harvard Medical School	College/University	Jeno Gyuris	Doctorate Degree
AstraZeneca LP AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE.	Pharmaceuticals: Major	Rachel Humphrey	Corporate Officer/Principal
IMMUNEERING CORPORATION	Pharmaceuticals: Major	Peter Feinberg	Director/Board Member
CYTOMX THERAPEUTICS, INC.	Pharmaceuticals: Major	Rachel Humphrey	Chief Tech/Sci/R&D Officer
XILIO THERAPEUTICS, INC.	Pharmaceuticals: Major	Rachel Humphrey	Director/Board Member
ILKOS THERAPEUTICS, Inc. ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology ILKOS THERAPEUTICS, Inc. operates as biotechnology firm. It develops drug and clinical solutions for the treatment of venous lower limb ulcers. The company is headquartered in Laval, Canada.	Biotechnology	Stephen Rubino	Director/Board Member
Trieza Therapeutics, Inc. Trieza Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trieza Therapeutics, Inc. provides pharmaceutical services. It engages in the developing immunomodulatory oncolytic viruses for the treatment of cancer. The company is headquartered in Cambridge, MA.	Pharmaceuticals: Major	Jeno Gyuris	Corporate Officer/Principal
BLACK DIAMOND THERAPEUTICS, INC.	Biotechnology	Rachel Humphrey	Chief Tech/Sci/R&D Officer
Tvardi Therapeutics, Inc. Tvardi Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tvardi Therapeutics, Inc. develops and commercializes medicines for the treatment of diverse cancers, chronic inflammatory and fibrotic diseases. The company was founded by David J. Tweardy and Ronald A. DePinho in 2017 and is headquartered in Houston, TX.	Miscellaneous Commercial Services	Michael Wyzga Jeno Gyuris	Director/Board Member Consultant / Advisor
OMEGA THERAPEUTICS, INC.	Biotechnology	Stephen Rubino	Corporate Officer/Principal
BRIDGEBIO PHARMA, INC.	Biotechnology	Peter Feinberg	Founder
PYXIS ONCOLOGY, INC.	Pharmaceuticals: Major	Rachel Humphrey	Director/Board Member
Glyscend, Inc. Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Glyscend, Inc. engages in the development of therapeutics for treating metabolic diseases. It focuses on providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. The company was founded by Kevin Colbert in September 2014 and is headquartered in Baltimore, MD.	Pharmaceuticals: Major	Michael Wyzga	Director/Board Member
Boxcar PMJ LLC Boxcar PMJ LLC Boxcar PMJ LLC is an Independent Venture Capital firm founded in 2019 by Peter Feinberg. The firm is headquartered in the US.		Peter Feinberg	Founder
Treadwell Therapeutics, Inc. Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY.	Pharmaceuticals: Major	Rachel Humphrey	Chief Tech/Sci/R&D Officer
Tio Bioventures Tio Bioventures Investment ManagersFinance Tio Bioventures (Tio Bioventures) is a venture capital firm founded in 2019 by Tak Wah Mak and Shane Burgess. The firm is headquartered in New York.	Investment Managers	Rachel Humphrey	Chief Tech/Sci/R&D Officer
Cure Ventures Management LP Cure Ventures Management LP Investment ManagersFinance Cure Ventures Management LP (Cure Ventures) is a venture capital firm founded in 2021 by David R Fallace, Richard J Lim and Lou A Tartaglia. The firm is headquartered in Boston, Massachusetts.	Investment Managers	Jeno Gyuris	Private Equity Investor
Asylia Therapeutics, Inc. Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan.	Pharmaceuticals: Major	Alex M. Cranberg Jeno Gyuris Rachel Humphrey	Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member
INVIVYD, INC.	Biotechnology	Michael Wyzga	Director/Board Member
Carina Biotech Pty Ltd. Carina Biotech Pty Ltd. BiotechnologyHealth Technology Carina Biotech Pty Ltd. is an immuno-oncology company based in Mawson Lakes, Australia. The Australian company is developing CAR-T and other adoptive cell therapies to treat solid cancers. Carina Biotech has a deep pipeline of CAR-T programs, including its LGR5-targeted CAR-T cell therapy CNA3103 for advanced colorectal cancer. The private company aims to improve access to and infiltration of solid cancers by CAR-containing cells, resulting in more potent and specific cancer killing and reduced off-target effects. Carina Biotech also has a fully integrated, proprietary manufacturing process that has both reduced manufacturing time and improved CAR-T cell quality, capable of delivering robust “serial-killing” CAR-T cells to patients. The CEO of the company is Deborah A. Rathjen.	Biotechnology	Michael Wyzga	Director/Board Member
VIRACTA THERAPEUTICS, INC.	Biotechnology	Stephen Rubino	Director/Board Member
EFFECTOR THERAPEUTICS, INC.	Biotechnology	Rachel Humphrey	Corporate Officer/Principal
Sermonix Pharmaceuticals LLC Sermonix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Sermonix Pharmaceuticals LLC operates as a pharmaceutical company that focuses on the development and commercialization of late-stage women?s health products. It offers lasofoxifene, a selective estrogen receptor modulator for the treatment of vulvovaginal atrophy, as well as treatment and prevention of post-menopausal osteoporosis. The company was founded in 2014 by David Portman and is headquartered in Columbus, OH.	Pharmaceuticals: Major	Stephen Rubino	Director/Board Member